Slides: SGLT-2 inhibitors in T2DM Management: Current Position & Future Promise
Slides (presentation) - Aug. 29, 2016 - ESC Rome 2016 - Silvio Inzucchi, MD New Haven, CT USA - PACE-CME symposium held at ESC 2016, RomeSlides prepared and presented by prof Silvio Inzucchi, MD - New Haven, CT, USA, at the PACE-CME symposium held at ESC 2016 in Rome, Italy
Disclosures
Prof Silvio Inzucchi MD, is Professor of Medicine at the Yale School of Medicine in New Haven, Connecticut, US, where he serves as Clinical Chief of the Section of Endocrinology and Medical Director of the Yale Diabetes Center
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
Share this page with your colleagues and friends: